Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm sure there are some frustrated traders. Or note holders.
someone is selling today
Holding steady, no buyers no sellers. Hopefully a strong signal.
It was a question on the wrong board...
Finally life in the otc is coming alive!
Present evidence of your claim please.
niceeeeeeeeeeeeeeeee.low float gem here
400K shares at 0.014. Let’s do this 💪
Some nice volume this morning, looks to be mainly buys.
Time to start getting some momo then maybe the tight lipped CEO will release something with substance.
Didn't they just anniunce a r=s?
Updating the website or some news would really help!!
Let’s see if tomorrow the market maters are just still trading amongst themselves as always. Would be nice to see a move up past .02 and hold.
Splitting hairs
6 digit close, wtf is happening
Also they recorded $310k first time revenue.
Everything's current so it will be a fast move up with an update due!!!….still such a tiny float….
I’ll wait. They diluted what 3mil shares in a quarter? Ha
Cnbx still a rare gem imo!!
“do a deal to get rid of noteholders somehow.”
Release news, get the price into a couple bucks and sell 500k shares to pay it off lol
Easy fix if they would just update investors…
Would be nice if they get rid of this 1.3M left of convertible debt.
Either they dilute it to 100M+ shares or they do a deal to get rid of noteholders somehow.
How can one find such an opportunity ;)
Yup. After 1 year of silence …..it’s about time they started updating investors imo!!
Along with their existing drugs. Add stem cells acquisition to the curiosity??
This is pretty much ripe for the picking.
?$$$ to be made
Market Cap Market Cap
373,336
12/08/2023
Authorized Shares
900,000,000
12/08/2023
Outstanding Shares
31,111,352
12/08/2023
Restricted
733,640
12/08/2023
Unrestricted
30,377,712
12/08/2023
Held at DTC
30,367,900
12/08/2023
Float
4,196,841
05/26/2023
I honestly believe Ceo's are stalling a little waiting for the Otc to start having more Volume/$$$
Right now why progress when the Market will trash you?
About 150M
Holly chit...
Lol. How many shares were outstanding when they had their last RS?
Float here still isn't bad. Even if we have 100 million shares on news it can still go up nicely.
Still here just been focusing on another bio stock atm.
Still believe this is a hidden gem. Sit tight and the company should give us an update at some point. 2024/2025 should be fun.
As always just my opinion and good luck.
Looks like you have a problem too. When someone talks lies, it’s always great to respond.
This is stock posting not UN Cheer leading
exactly 100%.....and in the next billionaire democrat rigged election and 8 more years and mission accomplished
USA officially a 3rd world commie/socialist country
Read the whole article . It Will Make You Sick !!! This is what it's like to live in a Republican controlled State all paid off by Billonaires
What makes me sick are the people who don’t support Israel. All backed and funded by democrat billionaires. Don’t shit where you eat sir.
Read the whole article . It Will Make You Sick !!! This is what it's like to live in a Republican controlled State all paid off by Billonaires
The U.S. Hemp Roundtable sent out a call-to-action alert following Monday’s committee vote, imploring supporters to contact their representatives and urge them to oppose the amendment package because it would prohibit the sale of full-spectrum hemp products
During a 30-minute hearing on Monday, the Senate General Government Committee voted 4-1 to attach the cannabis legislation to an unrelated House-passed bill on alcohol regulations
The chairman said the public only had until 2:30pm ET on Monday to submit comment on the cannabis legislation—just hours after it was unveiled and moved through committee during the brief hearing. No additional public testimony will be accepted on Tuesday or Wednesday before a potential vote to send it to the floor.
ttps://www.marijuanamoment.net/ohio-senate-committee-advances-bill-to-eliminate-marijuana-home-grow-reduce-possession-limits-and-raise-taxes-days-before-legalization-takes-effect/
Can anyone explain to me why the short interest here is over 10k%.
Only been one split in the last 10 years. But good try.
You must have bought this near 2 dollars several yrs ago.
I would normally say sorry for your loss, but since you’re still holding I won’t bother.
GLTU
With so much splits the account shows I paid $216 per share. To bad it was my wife's acct but good the investment was small.
Pretty convinced the note holder agreed not to impact their QB status. Curious who they plan to bring in as the new CTO since Goldberg left.
From 10-K
Sanja is no longer with the company but could be called back.
Have to admit I'm disappointed they issued 5 million shares for measly $50K 0.011...noteholder made a killing on the 0.04+ run in September...thought they would've converted at a higher price.
Need that debt to go down hard to do that when they keep converting around 0.011.
Sometime between yesterday evening and today.
What 8k, link please?
When did the 10k come out?
Think he meant 10K. It is audited so that’s good news. They seem to intend on keeping their QB status alive.
What 8k, link please?
Per 8K company is alive. Still in business. 2024/2025 will be huge!
Followers
|
183
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7472
|
Created
|
11/29/09
|
Type
|
Free
|
Moderators |
Outstanding: 4,966,197
Float: 4,196,841
Bringing Cannabinoid Diagnostics to Personalized Cancer Care
Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized diagnostic tools, aimed to provide supportive data for practitioners and patients regarding cannabinoid based therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations. Cannabics engages in delivering the maximum amount of supportive data for cancer patients and their doctors, utilizing advanced screening systems and personalized bioinformatics tools.
Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy.
The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.
The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process. The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.
Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.
Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations.
Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."
The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.
The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :
https://clinicaltrials.gov/ct2/show/NCT02359123
"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.
http://www.cannabics.com/investors
Market Value1 | $72,404,107 | a/o Jan 13, 2017 | |
Authorized Shares | 900,000,000 | a/o Dec 30, 2016 | |
Outstanding Shares | 107,265,344 | a/o Dec 30, 2016 | |
-Restricted | 90,368,887 | a/o Dec 30, 2016 | |
-Unrestricted | 16,896,457 | a/o Dec 30, 2016 | |
Held at DTC | Not Available | ||
Float | 14,295,638 | a/o Jun 30, 2016 | |
Par Value | 0.0001 |
Market Value1 | $37,994,466 | a/o Oct 28, 2016 | |
Authorized Shares | 900,000,000 | a/o Jul 09, 2015 | |
Outstanding Shares | 107,026,665 | a/o Jun 30, 2016 | |
-Restricted | Not Available | ||
-Unrestricted | Not Available | ||
Held at DTC | Not Available | ||
Float | 18,737,071 | a/o Jun 30, 2016 | |
Par Value | 0.0001 |
PER IHUB MGMT
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |